Allogene Therapeutics Inc (ALLO)
2.855
-0.18
(-6.09%)
USD |
NASDAQ |
Apr 25, 16:00
2.87
+0.02
(+0.53%)
After-Hours: 20:00
Allogene Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -142.6K% |
| June 30, 2023 | -177.2K% |
| March 31, 2023 | -189.8K% |
| December 31, 2022 | |
| September 30, 2022 | -169.7K% |
| June 30, 2022 | -86.96K% |
| Date | Value |
|---|---|
| March 31, 2022 | -130.9K% |
| December 31, 2021 | 0.11% |
| September 30, 2021 | -159.6K% |
| June 30, 2021 | -161.2K% |
| March 31, 2021 | -86.10% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-189.8K%
Minimum
Mar 2023
0.11%
Maximum
Dec 2021
-121.8K%
Average
-151.1K%
Median
Profit Margin (Quarterly) Benchmarks
| Agenus Inc | -55.24% |
| ANI Pharmaceuticals Inc | 0.88% |
| Vaxart Inc | -262.3% |
| aTyr Pharma Inc | -- |
| PAVmed Inc | -1.34K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -54.96% |
| Return on Assets | -44.29% |
| Return on Invested Capital | -54.96% |
| Return on Net Operating Assets | -177.1% |